The following table shows the list of Horizon 2020 projects developed by "MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | DiViNe | H2020-EU.2.1.4. | participant | 1˙397˙000.00 | 2015-03-01 | 1725 |
2 | ATLASS | H2020-EU.2.1.2.1. | participant | 405˙860.00 | 2015-03-01 | 1105 |
3 | EI3POD | H2020-EU.1.3.4. | partner | 0.00 | 2015-12-01 | 819 |
4 | CHEOPS | H2020-EU.3.3.2.4.;H2020-EU.3.3.2.2.;H2020-EU.3.3.2.1. | participant | 501˙353.00 | 2016-02-01 | 803 |
5 | PEARRL | H2020-EU.1.3.1. | participant | 249˙216.00 | 2016-05-01 | 675 |
6 | SYNTRAIN | H2020-EU.1.3.1. | partner | 0.00 | 2016-09-01 | 1239 |
7 | CORE | H2020-EU.1.3.1. | partner | 0.00 | 2016-10-01 | 828 |
8 | HyperOLED | H2020-EU.2.1.1. | coordinator | 1˙471˙729.00 | 2017-01-01 | 817 |
9 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 707 |
10 | PREFER | H2020-EU.3.1.7. | participant | 0.00 | 2016-10-01 | 664 |
11 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1033 |
12 | eTRANSAFE | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 899 |
13 | PARADIGM | H2020-EU.3.1.7. | participant | 0.00 | 2018-03-01 | 598 |
14 | TADFlife | H2020-EU.1.3.1. | participant | 252˙788.00 | 2018-10-01 | 416 |
15 | CHARMING | H2020-EU.1.3.1. | participant | 252˙788.00 | 2018-11-01 | 300 |
16 | ESCulab | H2020-EU.3.1.7. | participant | 0.00 | 2018-12-01 | 356 |
17 | IMMUcan | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 343 |
18 | MOBILISE-D | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 382 |
19 | ConcePTION | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 371 |
20 | MELLODDY | H2020-EU.3.1.7. | participant | 0.00 | 2019-06-01 | 408 |
totale | 4˙530˙734.00 |
This organization collaborated with partners in 31 countries.
Within the project DiViNe this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DK | Aquaporin A(S | AQUAPORIN AS (PRC) |
participant | FR | Affilogic | AFFILOGIC (PRC) |
participant | PT | GENIBET | GENIBET - BIOPHARMACEUTICALS SA (PRC) |
coordinator | PT | IBET | INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA (REC) |
participant | IT | GSK | GLAXOSMITHKLINE VACCINES SRL (PRC) |
Within the project ATLASS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FI | VTT | Teknologian tutkimuskeskus VTT Oy (REC) |
participant | DE | GRT | GRT GMBH&CO.KG.HAMM (PRC) |
participant | SE | TFE | THIN FILM ELECTRONICS AB (PRC) |
participant | AT | CONCEPT | CONCEPT TECH GMBH (PRC) |
participant | FR | EFFICIENT | EFFICIENT INNOVATION SAS (PRC) |
participant | FR | ICS | IN-CORE SYSTEMES (PRC) |
participant | UK | FE | FLEXENABLE LIMITED (PRC) |
participant | UK | SRC | THE SHADOW ROBOT COMPANY LIMITED (PRC) |
participant | FR | ARKEMA | ARKEMA FRANCE SA (PRC) |
coordinator | UK | MERCK | MERCK CHEMICALS LTD (PRC) |
participant | DE | AMO GMBH | GESELLSCHAFT FUR ANGEWANDTE MIKRO UND OPTOELEKTRONIK MIT BESCHRANKTERHAFTUNG AMO GMBH (PRC) |
participant | FI | VTT | TEKNOLOGIAN TUTKIMUSKESKUS VTT (REC) |
participant | NL | TU/e | TECHNISCHE UNIVERSITEIT EINDHOVEN (HES) |
participant | AT | JOR | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH (REC) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
Within the project EI3POD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | DE | Leica Microsystems GmbH (PRC) | |
partner | DE | Sanofi-Aventis Deutschland GmbH (PRC) | |
partner | DE | EMBLEM GmbH (PRC) | |
partner | NL | Nikon Instruments | Nikon Instruments Europe (PRC) |
partner | DE | Course Resource (PRC) | |
partner | DE | CELLZOME GMBH | CELLZOME GMBH (PRC) |
partner | DE | THERMO | Thermo Fisher Scientific GmbH (PRC) |
partner | UK | AZ | ASTRAZENECA UK LIMITED (PRC) |
partner | AR | MINCyT | Ministerio de Ciencia, Tecnología e Innovación Productiva (PUB) |
partner | US | STANFORD | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (HES) |
partner | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
partner | AU | MONASH UNIVERSITY | MONASH UNIVERSITY (HES) |
partner | CZ | MU | Masarykova univerzita (HES) |
partner | SE | UMU | UMEA UNIVERSITET (HES) |
partner | UK | UNILEVER | UNILEVER U.K. CENTRAL RESOURCES LIMITED (PRC) |
partner | NO | UiO | UNIVERSITETET I OSLO (HES) |
coordinator | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
partner | FI | UH | HELSINGIN YLIOPISTO (HES) |
partner | DK | AU-DMU | AARHUS UNIVERSITET (HES) |
Within the project CHEOPS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | OXFORD PV | OXFORD PHOTOVOLTAICS LIMITED (PRC) |
participant | NL | SMART | DE WILD-SCHOLTEN MARISKA (PRC) |
participant | CH | ACCEL | ACCELOPMENT AG (PRC) |
participant | UK | USAL | THE UNIVERSITY OF SALFORD (HES) |
participant | IT | UNITOV | UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA (HES) |
participant | FR | INERIS | INSTITUT NATIONAL DE L ENVIRONNEMENT ET DES RISQUES INERIS (REC) |
coordinator | CH | CSEM | CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT (REC) |
participant | CH | EPFL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (HES) |
participant | IE | UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PEARRL this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | EL | Pharmathen | PHARMATEN ANONYMOS VIOMICHANIKI KAI EMPORIKI ETAIREIA PHARMAKEFTIKON KAI KALLYNTIKON PROIONTON (PRC) |
participant | UK | Sirius | PION INC.(UK) LTD (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | UoA | ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (HES) |
participant | UK | BATH | UNIVERSITY OF BATH (HES) |
participant | CH | FHNW | FACHHOCHSCHULE NORDWESTSCHWEIZ (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
coordinator | IE | UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
Within the project SYNTRAIN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | FI | MISVIK | MISVIK BIOLOGY OY (PRC) |
participant | SE | KANCERA | KANCERA AB (PRC) |
participant | DK | DCS | KRAEFTENS BEKAEMPELSE (REC) |
participant | IT | IFOM | IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE (REC) |
participant | EL | UoA | ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (HES) |
participant | EL | LTSM-UPAT | PANEPISTIMIO PATRON (HES) |
partner | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | NKI AVL | STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (REC) |
coordinator | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project CORE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | NL | Corbion, Purac Biochem BV (PRC) | |
partner | NL | CHEMCONNECTION | CHEMCONNECTION BV (PRC) |
partner | RO | TeraCrystal | TeraCrysta SRL (PRC) |
partner | FR | PCAS | PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE SA (PRC) |
partner | UK | PSE | PROCESS SYSTEMS ENTERPRISE LIMITED (PRC) |
participant | NL | SCM | SYNCOM BV (PRC) |
participant | FR | URN | UNIVERSITE DE ROUEN NORMANDIE (HES) |
participant | DE | OVGU | OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
coordinator | UK | USTRAT | UNIVERSITY OF STRATHCLYDE (HES) |
participant | CH | ETH Zürich | EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (HES) |
partner | DE | MPIMP | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
participant | NL | RU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | FAU | FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG (HES) |
Within the project HyperOLED this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | LU | Intelligentsia | INTELLIGENTSIA CONSULTANTS SARL (PRC) |
participant | FR | MOD | MICROOLED SARL (PRC) |
participant | UK | UDUR | UNIVERSITY OF DURHAM (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PREFER this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
participant | DE | CSL | CSL BEHRING GMBH (PRC) |
participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
participant | BE | MB | MINDBYTES (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
participant | NL | ASTELLAS | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project eTRANSAFE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | JP | Eisai | EISAI CO LTD (PRC) |
participant | UK | Clarivate | CLARIVATE ANALYTICS (UK) LIMITED (PRC) |
participant | UK | PDS | PDS COMPUTER SOFTWARE LIMITED (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | UK | OPTIBRIUM | OPTIBRIUM LIMITED (PRC) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | UK | LL | LHASA LIMITED (REC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | MN | MOLECULAR NETWORKS GMBH COMPUTERCHEMIE (PRC) |
participant | UK | LJMU | LIVERPOOL JOHN MOORES UNIVERSITY (HES) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
coordinator | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project PARADIGM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project TADFlife this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | US | Schrödinger, LLC | Schrödinger, LLC (PRC) |
participant | NL | Simbeyond | SIMBEYOND BV (PRC) |
partner | JP | KOKURITSU DAIGAKU HOJIN KYUSHU DAIGAKU | NATIONAL UNIVERSITY CORPORATION KYUSHU UNIVERSITY (HES) |
participant | UA | IOP | INSTITUTE OF PHYSICS OF NATIONAL ACADEMY OF SCIENCE OF UKRAINE (REC) |
partner | JP | Kyoto University | National University Corporation, Kyoto University (HES) |
partner | KR | SNU | SEOUL NATIONAL UNIVERSITY (HES) |
partner | DE | BayFOR | BAYERISCHE FORSCHUNGSALLIANZ BAVARIAN RESEARCH ALLIANCE GMBH (OTH) |
partner | US | UNIV. S. CALIF. ISI | UNIVERSITY OF SOUTHERN CALIFORNIA (HES) |
partner | US | GIT | GEORGIA INSTITUTE OF TECHNOLOGY (HES) |
partner | US | ISU | IOWA STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY (HES) |
partner | LT | LC | LIGHT CONVERSION, UAB (PRC) |
participant | DE | UAU | UNIVERSITAET AUGSBURG (HES) |
participant | CH | FLUXIM | FLUXIM AG (PRC) |
participant | IT | UNIPR | UNIVERSITA DEGLI STUDI DI PARMA (HES) |
coordinator | DE | UBT | UNIVERSITAT BAYREUTH (HES) |
participant | UK | UDUR | UNIVERSITY OF DURHAM (HES) |
partner | IN | IISC | INDIAN INSTITUTE OF SCIENCE (HES) |
participant | LT | VU | VILNIAUS UNIVERSITETAS (HES) |
partner | NL | TU/e | TECHNISCHE UNIVERSITEIT EINDHOVEN (HES) |
participant | UK | USTAN | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (HES) |
Within the project CHARMING this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | LuGus Studios | LUGUS STUDIOS (PRC) |
partner | BE | ACTA | ACTA (OTH) |
partner | DE | HOCHSCHULE MANNHEIM | HOCHSCHULE MANNHEIM (HES) |
participant | DE | HS EL | HOCHSCHULE EMDEN/LEER (HES) |
participant | DK | ITU | IT-UNIVERSITETET I KOBENHAVN (HES) |
participant | FR | ARKEMA | ARKEMA FRANCE SA (PRC) |
partner | DE | BASF SE | BASF SE (PRC) |
partner | DE | UDE | UNIVERSITAET DUISBURG-ESSEN (HES) |
participant | DE | UNIBI | UNIVERSITAET BIELEFELD (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | UNIV.UTRECHT | UNIVERSITEIT UTRECHT (HES) |
coordinator | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project ESCulab this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | NL | MTR | MERCATORIAL BV (PRC) |
participant | NL | MLD | MERCALEADS BV (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | BSC | BIOASCENT DISCOVERY LIMITED (PRC) |
participant | NL | PPSC | PIVOT PARK SCREENING CENTRE BV (REC) |
participant | DE | TRS | TAROS CHEMICALS GMBH & CO KG (PRC) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | FR | EDL | EDELRIS SAS (PRC) |
participant | UK | SYG | SYGNATURE DISCOVERY LIMITED (PRC) |
participant | CH | MMV | Medicines for Malaria Venture (REC) |
coordinator | NL | LYG | STICHTING LYGATURE (OTH) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | SCM | SYNCOM BV (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | FR | IdRS | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | BE | IJB | INSTITUT JULES BORDET (HES) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | DDUV | DE DUVE INSTITUTE (REC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project MOBILISE-D this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | ERT | ERESEARCH TECHNOLOGY INC (PRC) |
participant | DE | PRI | PENUMOLOGISCHES FORSCHUNGSINSTITUTAN DER LUNGENCLINIC GROSSHANSDORF GMBH (PRC) |
participant | DE | BAY | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEV | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | IE | ICR | ICON CLINICAL RESEARCH LIMITED (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | ES | ISGLOBAL | FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (REC) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | IL | TASMC | THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV (REC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | RBMF | ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH (REC) |
participant | IT | UNISS | UNIVERSITA DEGLI STUDI DI SASSARI (HES) |
participant | FR | CHUM | CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER (OTH) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IT | USR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | UK | UNN | UNIVERSITY OF NORTHUMBRIA AT NEWCASTLE (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | CH | EPFL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (HES) |
participant | IE | UCD | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (HES) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | UK | USFD | THE UNIVERSITY OF SHEFFIELD (HES) |
participant | NO | NTNU | NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | DE | 01ZL FAU FAPS | FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG (HES) |
Within the project ConcePTION this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | ORC | ORCION BV (PRC) |
participant | BE | Bionotus | BIONOTUS (PRC) |
participant | NL | ENTIS | STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) FOUNDATION (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | DK | Ellegaard | ELLEGAARD GOTTINGEN MINIPIGS AS (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | NL | Elevate | ELEVATE BV (PRC) |
participant | AT | BBMRI-ERIC | BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) (REC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | FI | THL | TERVEYDEN JA HYVINVOINNIN LAITOS (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | IE | EIWH | EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE (REC) |
participant | NL | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | SE | SCC | REGION STOCKHOLM (PUB) |
participant | UK | NUTH | THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST (PUB) |
participant | IT | ARS | AGENZIA REGIONALE DI SANITA (OTH) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNIFE | UNIVERSITA DEGLI STUDI DI FERRARA (HES) |
participant | UK | USWAN | SWANSEA UNIVERSITY (HES) |
participant | UK | SGUL | ST GEORGE'S HOSPITAL MEDICAL SCHOOL (HES) |
participant | UK | Ulster | UNIVERSITY OF ULSTER (HES) |
participant | ZA | UKZN | UNIVERSITY OF KWAZULU-NATAL (HES) |
participant | FR | CHUT | CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | NO | UiO | UNIVERSITETET I OSLO (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project MELLODDY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | AmgenResMunich | AMGEN RESEARCH (MUNICH) GMBH (PRC) |
participant | FR | Iktos | IKTOS (PRC) |
participant | DE | Loodse GmbH | LOODSE GMBH (PRC) |
participant | FR | SubstraF | SUBSTRA (OTH) |
coordinator | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | NVIDIA SWISS AG | NVIDIA SWITZERLAND AG (PRC) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | HU | BME | BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |